LEADER 01986nmm a2200457 u 4500
001 EB001876051
003 EBX01000000000000001039418
005 00000000000000.0
007 cr|||||||||||||||||||||
008 191110 ||| eng
100 1 |a Bazan, Nicolas G. 
245 0 0 |a Photoreceptor protection  |h Elektronische Ressource  |b significance of docosanoids and elovanoids. Part 1 of 2, docosahexaenoic acid (DHA)  |c Nicolas Bazan 
246 3 1 |a significance of docosanoids and elovanoids. Part 1, Docosahexaenoic acid (DHA) 
246 3 1 |a Docosahexaenoic acid (DHA) 
260 |a London  |b Henry Stewart Talks  |c 2019, 2019 
300 |a 1 streaming video file (33 min.)  |b color, sound 
505 0 |a Biosynthesis of docosanoids -- Essential fatty acids -- Neuroprotective bioactivity during oxidative stress -- AdipoR1 as a regulatory switch of the DHA. 
653 |a Photoreceptor Cells / drug effects 
653 |a Docosahexaenoic Acids / pharmacology 
653 |a Oxidative stress 
653 |a Neuroprotective Agents 
653 |a Neuroprotection 
653 |a Retinal Pigment Epithelium / physiology 
653 |a Photoreceptors 
653 |a Fatty Acids, Omega-3 
653 |a Receptors, Adiponectin / metabolism 
653 |a Photoreceptor Cells / metabolism 
653 |a Neuroprotective agents 
653 |a Photoreceptor Cells / pathology 
653 |a Oxidative Stress 
653 |a Retinal degeneration / Prevention 
653 |a Macular Degeneration / prevention & control 
653 |a Fatty Acids, Essential 
653 |a Docosahexaenoic acid / Health aspects 
041 0 7 |a eng  |2 ISO 639-2 
989 |b HST  |a Henry Stewart Talks 
490 0 |a Macular degeneration 
500 |a Animated audio-visual presentation with synchronized narration. - Title from title frames. - Mode of access: World Wide Web 
856 4 2 |u https://hstalks.com/bs/p/979  |3 Series 
856 4 0 |u https://hstalks.com/bs/4033  |x Verlag  |z Streaming video file 
082 0 |a 570